Prostate Cancer
Mostrando 1-12 de 1194 artigos, teses e dissertações.
-
1. Qual é a orientação atualizada do Ministério da Saúde para rastreamento e prevenção do câncer da próstata?
O Instituto Nacional do Câncer (INCA) não recomenda o rastreamento do câncer de próstata, pois não há evidência científica que isto traga mais benefícios do que riscos.
”Em consonância com as evidências científicas disponíveis e as recomendações da OMS, a organização de ações de rastreamento para o câncer da próstata não é r
Núcleo de Telessaúde Bahia. Publicado em: 12/06/2023
-
2. Como diagnosticar e tratar pacientes com hiperplasia prostática benigna no âmbito da atenção primária à saúde?
A Hiperplasia Prostática Benigna (HPB) deve ser suspeitada especialmente em homens com mais de 50 anos, na presença de determinados sintomas urinários. O manejo de cada caso dependerá do tipo de sintoma predominante, dos achados clínicos e dos resultados de alguns exames complementares. A HPB é uma desordem urinária comum, cuja frequência aumenta
Núcleo de Telessaúde Santa Catarina. Publicado em: 12/06/2023
-
3. Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis
ABSTRACT Objective: To explore the feasibility of 68Ga-PSMA PET/CT in diagnosing primary prostate cancer. Materials and Methods: Embase, PubMed and Cochrane Library databases were searched for studies published before July 2020. The studies that used 68Ga-PSMA PET/CT for detecting primary prostate cancer, and pathological biopsy as the reference standard w
International braz j urol. Publicado em: 2022
-
4. Editorial Comment: Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer
International braz j urol. Publicado em: 2022
-
5. Prostate cancer mortality and costs of prostate surgical procedures in the Brazilian public health system
International braz j urol. Publicado em: 2022
-
6. Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: A systematic review and meta-analysis
ABSTRACT Background: This study aimed to explore the prevalence and clinical risk factors in patients diagnosed with incidental prostate cancer (IPC) during certain surgeries (transurethral resection of the prostate [TURP], open prostatectomy [OP], and holmium laser enucleation of the prostate [HoLEP]) after clinically suspected benign prostatic hyperplasia
International braz j urol. Publicado em: 2022
-
7. Recommendations for prostate cancer diagnosis and treatment during COVID-19 outbreak were not followed in Brazil
International braz j urol. Publicado em: 2022
-
8. Node dissection in prostate cancer: no answers for old questions
International braz j urol. Publicado em: 2022
-
9. Perception of castration value over cost in the metastatic prostate cancer scenario: a contemporary pharmacoeconomic perspective
International braz j urol. Publicado em: 2022
-
10. Impact of lifestyle in prostate cancer patients. What should we do?
ABSTRACT Objective: This review aimed to analyze interventions raised within primary and tertiary prevention concerning the disease's incidence, progression, and recurrence of Prostate Cancer (PCa). Priority was given to the multidisciplinary approach of PCa patients with an emphasis on modifiable risk factors. Materials and Methods: We conducted a compreh
International braz j urol. Publicado em: 2022
-
11. Available evidence on HIFU for focal treatment of prostate cancer: a systematic review
ABSTRACT Purpose: Prostate cancer (PCa) is the second most common oncologic disease among men. Radical treatment with curative intent provides good oncological results for PCa survivors, although definitive therapy is associated with significant number of serious side-effects. In modern-era of medicine tissue-sparing techniques, such as focal HIFU, have bee
International braz j urol. Publicado em: 2022
-
12. Association between Fecal Incontinence and Lower Urinary Tract Symptoms and their Impact on the Quality of Life of Patients with Prostate Cancer
Abstract Objective To evaluate the association of fecal incontinence (FI) and lower urinary tract symptoms (LUTS) in patients diagnosed with initial prostate cancer (PC) and after any therapeutic approach (surgery and radiotherapy). Methods Cross-sectional study using the Cleveland Clinic Incontinence Score (CCIS), the Fecal Incontinence Quality of Life
Journal of Coloproctology (Rio de Janeiro). Publicado em: 2022